ATE440593T1 - Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlíslichkeit - Google Patents

Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlíslichkeit

Info

Publication number
ATE440593T1
ATE440593T1 AT02737899T AT02737899T ATE440593T1 AT E440593 T1 ATE440593 T1 AT E440593T1 AT 02737899 T AT02737899 T AT 02737899T AT 02737899 T AT02737899 T AT 02737899T AT E440593 T1 ATE440593 T1 AT E440593T1
Authority
AT
Austria
Prior art keywords
biologically active
lipid particles
container
lipophilic
solubilizing
Prior art date
Application number
AT02737899T
Other languages
English (en)
Inventor
Steve Leigh
Mathew Louis Steven Leigh
Hoogevest Peter Van
Henricus Tiemessen
Original Assignee
Phares Pharm Res Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phares Pharm Res Nv filed Critical Phares Pharm Res Nv
Application granted granted Critical
Publication of ATE440593T1 publication Critical patent/ATE440593T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT02737899T 2001-03-27 2002-03-26 Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlíslichkeit ATE440593T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01302841 2001-03-27
PCT/EP2002/003371 WO2002080883A2 (en) 2001-03-27 2002-03-26 Method and composition for solubilising a biologically active compound with low water solubility

Publications (1)

Publication Number Publication Date
ATE440593T1 true ATE440593T1 (de) 2009-09-15

Family

ID=8181836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02737899T ATE440593T1 (de) 2001-03-27 2002-03-26 Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlíslichkeit

Country Status (11)

Country Link
US (2) US20040115255A1 (de)
EP (1) EP1389089B1 (de)
JP (3) JP2004524368A (de)
AT (1) ATE440593T1 (de)
AU (1) AU2002312777B2 (de)
CA (1) CA2442539C (de)
DE (1) DE60233484D1 (de)
DK (1) DK1389089T3 (de)
ES (1) ES2332584T3 (de)
PT (1) PT1389089E (de)
WO (1) WO2002080883A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7444383B2 (en) 2000-06-17 2008-10-28 Microsoft Corporation Bounded-deferral policies for guiding the timing of alerting, interaction and communications using local sensory information
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
DE10203923B4 (de) * 2002-01-31 2011-06-01 Klinipharm Gmbh Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung
EP1670434A4 (de) * 2003-10-02 2010-06-23 Sembiosys Genetics Inc Verfahren zur herstellung von ölkörpern mit wirkstoffen
WO2005065677A1 (ja) * 2004-01-09 2005-07-21 Otsuka Pharmaceutical Factory, Inc. パクリタキセルまたはドセタキセルを溶解または分散させるための脂肪乳剤
WO2005105041A2 (en) * 2004-04-27 2005-11-10 Formatech, Inc. Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
EP3424508B1 (de) 2004-05-19 2021-05-05 Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Verwendung von natriumdeoxycholat zum entfernen einer lokalisierten fettanhäufung
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
CA2584583A1 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
DE602006017979D1 (de) * 2005-03-14 2010-12-16 Otsuka Pharma Co Ltd Kit enthaltend einen wirkstoff und eine fettemulsion
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
JP5342834B2 (ja) * 2008-09-05 2013-11-13 日東電工株式会社 骨髄線維症処置剤
KR101975843B1 (ko) * 2008-05-23 2019-05-09 더 유니버시티 오브 브리티쉬 콜롬비아 리포좀 나노입자에 사용하기 위한 변형된 약물
DK2344198T3 (da) * 2008-09-27 2020-11-30 Jina Pharmaceuticals Inc Lipidbaserede farmaceutiske præparater til topisk anvendelse
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20170340563A1 (en) * 2009-09-23 2017-11-30 Curirx Inc. Methods for the Preparation of Liposomes Comprising Drugs
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US8591942B2 (en) 2009-09-23 2013-11-26 Indu JAVERI Methods for the preparation of liposomes comprising docetaxel
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
BR112013014291A2 (pt) * 2010-12-08 2016-09-20 Hoffmann La Roche formulação lipossômica de calcetrapib
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
WO2013176223A1 (ja) * 2012-05-23 2013-11-28 国立大学法人大阪大学 炎症性疾患治療用医薬組成物
EP2682106A1 (de) 2012-07-03 2014-01-08 Phares Pharmaceutical Research N.V. Verfahren zum Auflösen biologisch aktiver Verbindungen
AU2016367543A1 (en) 2015-12-07 2018-05-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions of therapeutic substances, methods and uses thereof
LT3532067T (lt) 2016-10-28 2022-08-25 Les Laboratoires Servier Liposominė vaisto forma, skirta naudoti gydant vėžį
CA3063395A1 (en) * 2017-05-12 2018-11-15 Curinanorx, Llc Methods for the preparation of liposomes comprising drugs

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
JP2688235B2 (ja) * 1987-09-07 1997-12-08 帝人株式会社 医薬物質含有脂肪乳剤の用時調製型キットおよび医薬物質含有脂肪乳剤の調製方法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
HK1007497A1 (en) * 1990-07-31 1999-04-16 利普索姆公司 Accumulations of amino acids and peptides into liposomes
WO1994020514A1 (fr) * 1993-03-04 1994-09-15 Mect Corporation Compose associe au systeme de lewis, procede d'obtention de ce compose et anti-inflammatoire
DE19609538A1 (de) * 1996-03-11 1997-09-18 Basf Ag Feinverteilte Carotinoid- und Retinoidsuspensionen und Verfahren zu ihrer Herstellung
NZ267310A (en) * 1993-05-21 1996-09-25 Liposome Co Inc Liposome compositions with reduced adverse physiological reactions
EP0633024A1 (de) * 1993-07-09 1995-01-11 Ciba-Geigy Ag Topisch verabreichbare Zink Phthalocyanin haltige Mittel
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
JP4221515B2 (ja) * 1994-05-23 2009-02-12 セファロン リミテッド 製剤調製機
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US6447800B2 (en) * 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
EP0974364A4 (de) * 1996-10-25 2000-12-20 Yoshitomi Pharmaceutical Verfahren zur verhinderung der ausfällung von arzneistoffen
ATE240088T1 (de) * 1996-12-13 2003-05-15 Vesifact Ag Kosmetische präparate in form einer nanodispersion
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
AU4650899A (en) * 1998-07-10 2000-02-01 Welfide Corporation Kit of drug-containing preparation to be prepared before using and resolvent therefor
DE19843968A1 (de) * 1998-09-24 2000-04-13 Hans Dietl Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung
US6682758B1 (en) * 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
AU777572B2 (en) * 1999-04-01 2004-10-21 Board Of Regents, The University Of Texas System Compositions and methods for treating lymphoma
US20030144570A1 (en) * 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
US20020001613A1 (en) * 2000-02-08 2002-01-03 Susan Niemiec Method of manufacturing liposomes

Also Published As

Publication number Publication date
WO2002080883A3 (en) 2003-12-11
DE60233484D1 (de) 2009-10-08
AU2002312777B2 (en) 2007-07-05
CA2442539C (en) 2011-11-08
JP2010013461A (ja) 2010-01-21
DK1389089T3 (da) 2009-12-21
CA2442539A1 (en) 2002-10-17
EP1389089B1 (de) 2009-08-26
US20040115255A1 (en) 2004-06-17
EP1389089A2 (de) 2004-02-18
US20080131499A1 (en) 2008-06-05
WO2002080883A2 (en) 2002-10-17
AU2002312777A2 (en) 2002-10-21
JP2012207042A (ja) 2012-10-25
JP2004524368A (ja) 2004-08-12
PT1389089E (pt) 2009-11-30
ES2332584T3 (es) 2010-02-09

Similar Documents

Publication Publication Date Title
DE60233484D1 (de) Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlöslichkeit
CA1179235A (en) Preparation of a gel having gas transporting capability and the resulting gel
AU691283B2 (en) Taxane class derivative based pharmaceutical compositions
ATE260651T1 (de) Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
BR0116377A (pt) Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria
HUT44168A (en) Process for production of composition assuring eventual homogene suspension of particles containing active substance
ATE476985T1 (de) Von thrombozyten stammende wachstumsfaktorzusammensetzungen und anwendungsverfahren dafür
FR2561916B1 (fr) Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
ATE307611T1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
NO992068D0 (no) Mikroemulsjon og fremgangsmÕte for fremstilling av denne
EP1226109A4 (de) Phenylamin-carbonsäure-verbindungen und zubereitungen zur verabreichung von wirkstoffen
DE60327994D1 (de) Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
DE60039450D1 (de) Zusammensetzungen und methoden zur stabilisierung von biologischen molekülen nach lyophilisierung
CA2463681A1 (en) Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
HRP20040882B1 (hr) Stabilni farmaceutski pripravak koji sadrži faktor viii
JP2008036438A (ja) 骨代用材料
JPS638339A (ja) 非経口投与用医薬組成物
DE69917681T2 (de) Zusammensetzungen und verfahren zum konservieren von blutplättchen
CA2452395A1 (en) Pharmaceutically stable hemostatic compositions
ATE183639T1 (de) Zusammensetzung zur verwendung in der transdermalen verabreichung
ATE358507T1 (de) Herstellung von dialysekonzentrat aus einer hochverdichteten konzentratvorstufe und vorrichtung zur anwendung am dialyseplatz.
ATE298567T1 (de) Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung
GB2105589A (en) Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
JPH0678241B2 (ja) ｔＰＡ医薬組成物
AU672430B2 (en) Antithrombin III preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties